Boehringer Ingelheim: WSC 2018 – Secondary stroke Prevention: new Evidence that Demands a Verdict

1) Stroke prevention in AF: latest insights on NOACs
Richard Bernstein, USA

2) Every minute counts: dabigatran reversal in neurological emergencies
Thorsten Steiner, Germany

3) Implications from RE-SPECT ESUS 
Hans-Christoph Diener, Germany

4) Patients with ESUS: diagnosis and current treatment options 
Mike Sharma, Canada

LEAVE YOUR COMMENT

Your email address will not be published.